Global Vocal Biomarker Market

1. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % Global Vocal Biomarker Market size- Industry Trends & Outlook Report 2026 View report Sample report Press release Summary According to Blueweave Consulting, the Global Vocal Biomarker Market is anticipated to reach USD 4.2 Billion in 2026 from USD 1.73 Billion in 2019, at CAGR of 13.7% during the projected period 2020-2026. Global Vocal Biomarker is a medical device used for early detection of diseases, and its market is driven by the prevalence of neurological and psychological diseases and the urgency of diseases detection. Besides, its cost-efficiency and technological advancements induce market growth. The market has been growing at a steady rate during the past few years. At present, the Pharma companies and the healthcare sector are exploring its applications and potential in the medical field. The security agencies and defence organizations are increasingly using Vocal Biomarker for the lie-detecting test of the suspects. The market holds tremendous growth potential due to technological advancements, including AI and is expected to register growth during the forthcoming period. Vocal Biomarker is a device which detects ailments based on the voice pattern of the patient. It is a minimally invasive technique deployed for the diagnosis of diseases in the initial stage. It serves as a substitute for MRI, X-Ray and CT Scan in medical urgencies. The advance uses of this technique facilitate diagnosis and treatment of diseases besides lie-detection tests.

2. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % Global Vocal Biomarker Market size- Industry Trends & Outlook Report 2026 The Global Vocal Biomarker Market size is estimated at USD 1.73 billion in 2019, and it is expected to reach USD 4.2 billion at a CAGR of 13.6 % during projection period 2020-2026. The market for Vocal Biomarker (a device to detect diseases by speech characteristics) is dependent on the prevalence of psychological, neurological and other diseases affecting speech and the urgency of detection of the severe illness. Besides, its cost efficiency and early detection of diseases drive the market growth. The market has been growing at a steady rate over the past few years. And, it is expected to grow extensively during the projection period. The pharmaceutical companies are exploring the potential of the market further as they help in healthcare and drug sales. The defence and security agencies increasingly use it as a lie-detector test. Global Vocal Biomarker Market Overview Recent discoveries in the medical sector have led to the development of an exceptional diagnostic tool known as a vocal biomarker, by linking the concept of biological markers with the vocal pattern to analyze personality traits. Vocal Biomarker is a new medical device used to detect diseases based on voice pattern. It is a cost-efficient and minimally invasive technique which helps detect illnesses in the initial stage. Vocal Biomarker finds application in detection of diseases as well as in the detection of liar suspects. Besides medical practices, it is used by defence organizations and security agencies while probing a defendant. It serves as a substitute for MRI, X-Ray and CT scan in some medical urgency. The advanced uses of this technique are likely to promote its market during the projected period. Global Vocal Biomarker Market Outlook and Trends Growth drivers Prevalence of Parkinson's Disease and other diseases induce the demand for Vocal Biomarker As per a study of Parkinson's Foundation, more than 10 million across the globe suffer from Parkinson's disease. The prevalence, risk, early detection requirement and increasing cases of this disease lead to the more demand for vocal Biomarker, assuring strong growth potential for the market. Besides, the rising incidence of traumatic brain injury, cardiovascular & psychological diseases and respiratory disorders will also drive the market during the projection period.

3. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % Growing Applications in Healthcare and Other fields The vocal biomarkers are finding their application in remote health monitoring of the heart-patient, in the testing voice of the patient with coronary artery disease and recognizing depression and stress among callers besides early detection of diseases in healthcare and lie-detection in security agencies. Such applications are expected to amplify the market for vocal biomarkers. Restraints Accuracy Issues restrict the market growth. The accuracy of the vocal Biomarker may vary with the use of complex words and the environments of speech recording. Also, collection, processing and analysis of speech data raise doubts related to its quality. Besides, the inability to extract the desired vocal features, significant errors in the vocal features and inaccuracies of boundaries of words also restrict the use of vocal Biomarker, hampering its growth of the market. Impact of COVID-19 in industry The overall slowdown has been registered in economic activities across the globe. However, people in every sector have learned to maintain social distancing and to work remotely. The vocal Biomarker serves as a remote sensor for patients with fatal diseases and helps to recognize a medical emergency. In COVID times, its application is more relevant and is being deployed in different countries for different medical purposes. Global Vocal Biomarker Market: Segmentation The Vocal Biomarker market is segmented into four categories viz., Type, Indications, Neurological Disorders and End-user. The Type category is divided into Frequency, Amplitude, Error Rate, Voice Rise/fall time, Phonation Time, Voice Tremor, Pitch and Others. The Indication category is subdivided into Depression, Attention Deficit and Disruptive Behavior Disorders and Others. The Neurological Diseases Category is again divided into Parkinson's Disease, Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, Traumatic Brain Injury and Others. The end-user category consists of Hospitals and Clinics, Academic and Research, Others. In the first category based on type, the voice tremor segment is expected to register significant growth due to rising neurological disorders and growing

4. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % application of vocal Biomarker in it. In indication category of various diseases, the respiratory diseases segment is anticipated to witness significant growth on account of the prevalence of respiratory diseases and ongoing research on the use of biomarkers in asthma conditions. In the end-user segment, the healthcare sector is likely to observe more applications and more usage of vocal Biomarker during the projection period. Global Vocal Biomarker Market: Regional Insights North America is characterized by well-established healthcare facilities and technological advancements, so it is likely to dominate the Global Vocal Biomarker Market during the projection period. Besides, easy medical reimbursement policies and increasing healthcare expenditure in the region contribute to the growth of the market. Europe is the second most promising market driven by increasing healthcare outlay and rising income & awareness. Asia Pacific region is expected to register growth driven by the markets in China, India, Japan and South Korea. The Middle East and Africa region is anticipated to register the lowest growth on account of technological impediments and poor economic and political conditions. Competitive landscape The technological advancements are instilling fierce competition among existing players in Global Vocal Biomarker Market. They are keen on acquiring new technologies, including AI, to improve their market share. The leading players in this market are Sonde Health(US), Beyond Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation, Microtest Health and others. Recent Developments August 3, 2020: Sonde Health develops a workplace safety tool with voice biometrics. Facial recognition, temperature recognition, wearable and voice biometrics are being deployed COVID-19 spread prevention across the world. December 12, 2019: Israeli health tech firms- Beyond Verbal and Healthymize merge to advance AI-powered vocal biomarkers. Scope of the Report Attribute Years Considered Details Historical data – 2016-2019 Base Year – 2019 Forecast – 2020 – 2026 Facts Covered Revenue in USD Billion

5. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % Market Coverage U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Mexico, Japan, South Korea, China, India, South Korea UAE, South Africa, Saudi Arabia. By Type, Indications, Disorders and End User Sonde Health(US), Beyond Verbal (Israel), IBM Corporation (US), Cogito Corporation (US), Boston Technology Corporation, Microtest Health Product/Service Segmentation Neurological Key Players By Type ØFrequency ØAmplitude ØError Rate ØVoice Rise/fall time ØPhonation Time ØVoice Tremor ØPitch ØOthers By Indications ØDepression ØAttention Deficit ØDisruptive Behavior Disorders ØOthers By Neurological Disorders ØParkinsons Disease ØAlzheimer’s Disease ØHuntington’s Disease ØRespiratory and Cardiovascular Disorders ØTraumatic Brain Injury By End-use ØHospitals and Clinics ØAcademic and Research ØOthers By Region: ØNorth America ØEurope ØAsia Pacific ØLatin America ØMiddle East & Africa

6. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % The objective of the Study: ØTo analyze and estimate the Global Vocal Biomarker Market size, in terms of value. ØTo examine the market segmentation carefully and estimate the market size, in terms of value, based on the region by segmenting the Global Vocal Biomarker Market into five regions, namely, North America, Europe, Asia Pacific, Rest of the World and their leading countries. ØTo outline, categorize and project the Global Vocal Biomarker Market based on the By Type, Indications, Neurological Disorders and End User. ØTo examine competitive developments in application areas, technology and diverse industry usage within the Global Vocal Biomarker Market. ØTo highlight market dynamics such as drivers, restraints, opportunities, and challenges and their impact. ØTo provide a detailed competitive landscape, including major players, their strategic profiles, and market shares. Business Questions Answered by the Report: ØHow will the market drivers, restraints, and opportunities affect the market dynamics? ØWhat will be the market size in terms of value and volume and market statistics with a detailed classification? ØWhich segment dominates the market or region, and which one will be the fastest-growing, and why? ØWho are the key players in the market, and what is their share? ØWhat is the strategy adopted by key players, and how does it affect the existing and new players? Customization Scope for the Client: Client satisfaction is our first and last priority, and that is why BlueWeave Consulting offers customization as per client’s specific needs. The following customization options are available for the report: ØAdditional Company Information ØDetail Analysis of five additional companies ØAdditional country analysis ØDetailed segment analysis

7. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 % About us Blueweave Consulting offers a one-stop solution for your market intelligence needs for any service or product. You get well-researched comprehensive reports based on qualitative and quantitative data to put your business plan into action. Your well informed and timely decisions using our reports avert situations of excessive risks and help you grow your business with optimum risk-return trade- off. Delivering quality insights into several product or service markets within the timeline as per the needs of the clients has earned BWC an excellent reputation among clients. BWC strives to provide timely and accurate digital market intelligence services for making your business endeavours successful. For more information, kindly visit our Website www.blueweaveconsulting.com contact us info@blueweaveconsulting.com

8. Global Vocal Biomarker Market revenues to Reach USD 4.2 Billion in 2026 at a significant CAGR of 13.7 %